LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・MacroGenics Inc

MacroGenics Inc

Closed

Sector Healthcare

3.26 -2.98

Buy Sell

Overview

Share price change

24h

Current

Min

3.23

Max

3.27

Key metrics
By Trading Economics
Income	-52M
Sales	-1.6M 9.1M
EPS	-0.84
Profit margin	-573.264
Employees	339
EBITDA	-49M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+114.5 upside

Dividends
By Dow Jones
Next Earnings	4 lis 2024

Market Stats
By TradingEconomics
Market Cap	-6.6M 219M
Previous open	6.24
Previous close	3.26

News Sentiment

By Acuity

83%

17%

327 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

3.24 / 3.38 Support & Resistance

MacroGenics Inc Chart

Related News

6 wrz 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

6 wrz 2024, 21:18 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

6 wrz 2024, 21:05 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

6 wrz 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

6 wrz 2024, 20:39 UTC

Earnings

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

6 wrz 2024, 20:35 UTC

Top News

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

6 wrz 2024, 20:34 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

6 wrz 2024, 20:11 UTC

Top News

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

6 wrz 2024, 19:51 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

6 wrz 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

6 wrz 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

6 wrz 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

6 wrz 2024, 18:27 UTC

Top News

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

6 wrz 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

6 wrz 2024, 18:15 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

6 wrz 2024, 18:12 UTC

Top News

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

6 wrz 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

6 wrz 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

6 wrz 2024, 17:30 UTC

Top News

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

6 wrz 2024, 17:27 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

6 wrz 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 wrz 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

6 wrz 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

6 wrz 2024, 16:35 UTC

Earnings

Hot Stocks

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

6 wrz 2024, 16:33 UTC

Acquisitions, Mergers, Takeovers

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

6 wrz 2024, 16:20 UTC

Market Talk

Earnings

Tech, Media & Telecom Roundup: Market Talk

6 wrz 2024, 16:20 UTC

Earnings

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

6 wrz 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

6 wrz 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 wrz 2024, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

Peer Comparison

Price change

MacroGenics Inc Forecast

Price Target

By TipRanks

114.5% upside

12 Months Forecast

Average 7.25 USD 114.5%

High 14 USD

Low 4 USD

Based on 12 Wall Street analysts offering 12 month price targets forMacroGenics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to MacroGenics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

3.24 / 3.38Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

327 / 365 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About MacroGenics Inc

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology platforms and also in collaboration with other biopharmaceutical companies. It has a pipeline of product candidates in human clinical testing, primarily as treatments for different types of cancers, which are created using its technology platforms. Its clinical product candidate, margetuximab, has been enhanced using its Fc Optimization platform. The Company is also developing several product candidates targeting B7-H3, a protein in the B7 family of immune regulator proteins. The Company's product candidates also include enoblituzumab and MGD009, MGC018, MGD006 (flotetuzumab), MGD007, MGD011 (duvortuxizumab), PF-06671008 and MGD010.